Publications (12) Publications de Susana de la Cruz Sánchez

2024

  1. Spanish Society of Medical Oncology recommendations for comprehensive assessment and care of cancer survivors’ needs

    Clinical and Translational Oncology

2023

  1. Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies

    Biomedicines, Vol. 11, Núm. 2

2021

  1. A dna methylation-based gene signature can predict triple-negative breast cancer diagnosis

    Biomedicines, Vol. 9, Núm. 10

  2. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer

    Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1272-1280

2020

  1. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    The Lancet Oncology, Vol. 21, Núm. 4, pp. 519-530

2017

  1. CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

    Clinical Epigenetics, Vol. 9, Núm. 1

2015

  1. 37th Annual San Antonio Breast Cancer Symposium. Summary of the most important translational and clinical contributions

    Revista de Senologia y Patologia Mamaria

2010

  1. Adjuvant endocrine therapy in premenopausal women with breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. SUPPL. 1, pp. 43-47

  2. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465

2008

  1. Hormonal therapy in breast cancer

    Revista de medicina de la Universidad de Navarra, Vol. 52, Núm. 1, pp. 40-48

2007

  1. Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule

    Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 465-467

  2. Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy

    Oncologist, Vol. 12, Núm. 9, pp. 1151-1155